Menu Search
Equities

Patterson Companies Inc

PD2:DUS

Patterson Companies Inc

Actions
  • Price (EUR)22.60
  • Today's Change0.20 / 0.89%
  • Shares traded200.00
  • 1 Year change-19.86%
  • Beta--
Data delayed at least 15 minutes, as of Jun 25 2024 07:10 BST.
More ▼
Improved Notifications for Markets Data Alerts
Improved Notifications for Markets Data Alerts
Want push notifications sent directly to your devices for equity price changes and breaking news stories? Let us know here.
 
Existing alertsView our existing alerts
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Patterson Companies, Inc. is a value-added specialty distributor serving the United States and Canadian dental supply markets and the United States, Canadian and United Kingdom animal health supply markets. The Company’s segments include Dental, Animal Health and Corporate. Its Dental segment provides consumable products (including infection control, restorative materials, and instruments); basic and advanced technology and dental equipment, and practice optimization solutions, including practice management software, e-commerce, revenue cycle management, patient engagement solutions, and clinical and patient education. Its Animal Health segment is a full-line distributor in North America and the United Kingdom of animal health products, services and technologies to both the production-animal and companion-pet markets. It offers a private label portfolio of products to veterinarians, producers, and retailers through its Aspen, First Companion and Patterson Veterinary brands.

  • Revenue in USD (TTM)6.57bn
  • Net income in USD185.93m
  • Incorporated1992
  • Employees7.60k
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.